The company will use the funds to advance its drug design platform and lead program in EGFR-expressing solid tumors and expand globally.
The company also announced the appointment of Han Lee, Ph.D., as co-chief executive officer (CEO), and the U.S. Food and Drug ...
The U.S. operation in Venezuela reflects a strategic logic designed by a group of George W. Bush’s advisers: to expand U.S.